Cite This Page
Bibliographic details for Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects
- Page name: Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 15 January 2024 10:47 UTC
- Date retrieved: 15 May 2024 13:18 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037
- Page Version ID: 531037
Citation styles for Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects
APA style
Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects. (2024, January 15). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 13:18, May 15, 2024 from https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037.
MLA style
"Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 15 Jan 2024, 10:47 UTC. 15 May 2024, 13:18 <https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 15 January 2024, 10:47 UTC, <https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037> [accessed 15 May 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037 (accessed May 15, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 15, 10:47 UTC [cited 2024 May 15]. Available from: https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037.
Bluebook style
Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects, https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037 (last visited May 15, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037", note = "[Online; accessed 15-May-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Progression of Multifunctional and also Orally Energetic Cyclic Peptide Agonists regarding OpioidNeuropeptide FF Receptors that leave Potent LongLasting and Peripherally Restricted Antinociception together with Declined Negative effects --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Progression_of_Multifunctional_and_also_Orally_Energetic_Cyclic_Peptide_Agonists_regarding_OpioidNeuropeptide_FF_Receptors_that_leave_Potent_LongLasting_and_Peripherally_Restricted_Antinociception_together_with_Declined_Negative_effects&oldid=531037}", note = "[Online; accessed 15-May-2024]" }